AI-assisted summary

Researchers found that advanced cancer patients who received a COVID-19 mRNA vaccine near the start of immunotherapy lived significantly longer.

The study analyzed over 1,000 patient records for advanced lung and skin cancers from MD Anderson Cancer Center.

The findings suggest that mRNA vaccines may boost the immune system's ability to fight tumors, potentially leading to a universal cancer vaccine.

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.

The observation by researchers at the University of Florida and the University of Texas MD Anderson Cancer Center is a defining moment in a decade-plus

See Full Page